Potential for Other Conditions Beyond EPP, researchers have explored the use of afamelanotide and other melanocortin agonists for conditions such as vitiligo, a disorder characterised by loss of skin pigmentation, and polymorphous light eruption (PLE), a form of sun allergy
GLP-1 is a protein molecule that your body naturally makes that is produced inside the intestine, that decreases blood sugar and regulates your appetite
Another drug that hits the same receptor, dulaglutide, has also been available to treat diabetes for years
One particularly compelling case series examined patients who prioritized muscle preservation strategies during semaglutide and tirzepatide treatment
Food and Drug Adminstration is called orforglipron
The key differences are in their receptor profiles (tirzepatide targets both GIP and GLP-1 receptors, while semaglutide targets GLP-1 only ) and their dose conversion ratios